Palivizumab prophylaxis in preterm infants

Lancet Respir Med. 2017 Mar;5(3):171. doi: 10.1016/S2213-2600(17)30050-4. Epub 2017 Feb 15.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature*
  • Palivizumab / therapeutic use*
  • Preventive Medicine / methods
  • Respiratory Syncytial Virus Infections / prevention & control*
  • Respiratory Syncytial Viruses / drug effects

Substances

  • Antiviral Agents
  • Palivizumab